2008
DOI: 10.1016/j.ijpharm.2008.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Parenteral microemulsions: An overview

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
90
0
17

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(112 citation statements)
references
References 58 publications
5
90
0
17
Order By: Relevance
“…Usually, the oil which has maximum solubilising potential for selected drug candidate is selected as an oily phase for the formulation of nanoemulsions. This helps to achieve maximum drug loading in the nanoemulsions [14]. Mixture of oils can also be used to solubilsed the maximum amount of drug [15].…”
Section: Components Of Nanoemulsionmentioning
confidence: 99%
“…Usually, the oil which has maximum solubilising potential for selected drug candidate is selected as an oily phase for the formulation of nanoemulsions. This helps to achieve maximum drug loading in the nanoemulsions [14]. Mixture of oils can also be used to solubilsed the maximum amount of drug [15].…”
Section: Components Of Nanoemulsionmentioning
confidence: 99%
“…Lorazepam (LZM) is a poorly water-soluble drug which can be used as a tranquillizer, muscle relaxant, sleep inducer, sedative and antiepileptic agent [40]. Co-solvent based parenteral formulations, however, have several disadvantages, such as pain and tissue damage at the site of injection and precipitation of the drug on dilution in several cases [41]. Furthermore, parenteral administration of the organic co-solvents can also cause hemolysis [42].…”
Section: Treatment Of Epilepsy and Schizophreniamentioning
confidence: 99%
“…22 However, the utility of these approaches is often restricted because of poor stability, complexity associated with manufacturing, and unqualified bioavailability, which makes them unsuitable for large-scale production and clinical application. 23 Liquid NPs have proved an effective vehicle that could increase the bioavailability for many drugs. 24,25 Our previous study has shown that liquid NPs for intravenous administration exhibiting better bioavailability and no systemic toxicity may act as a potential Tan IIA vehicle for clinical application.…”
Section: Introductionmentioning
confidence: 99%